Form 4: Precipio Inc. Director Cossman Jeffrey Reports Stock Option Repricing

Director Jeffrey Cossman reports repricing of stock options at Precipio, Inc. effective August 31, 2024.

Summary

• Jeffrey Cossman, a director at Precipio, Inc., filed a Form 4 detailing changes in beneficial ownership due to a stock option repricing.
• The repricing, approved by the Issuer's Board of Directors on August 30, 2024, became effective on August 31, 2024.
• The exercise price of the options was adjusted to $6.56 per share, reflecting the fair market value of Precipio's common stock on the effective date.
• Cossman acquired new options at the $6.56 price and disposed of old options with various strike prices.
• The repriced options will revert to their original exercise price if Cossman's service with the Issuer is terminated with cause or by Cossman, or if the option is exercised before the first anniversary of the effective date.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports a stock option repricing, which is neither inherently positive nor negative. The impact depends on the company's future performance and the director's contribution.

Positives

• The repricing aligns the option exercise price with the current fair market value of the company's stock, which could incentivize the director.
• The repricing may help retain the director by providing more valuable stock options.

Negatives

• The repricing could be seen negatively if the stock price does not increase, as it essentially provides the director with a lower strike price without additional performance requirements.
• The potential reversion to the original exercise price under certain termination scenarios could be viewed as a clawback provision.

Risks

• The repricing may not have the intended effect of incentivizing the director if the stock price declines.
• The reversion clause could create uncertainty for the director regarding the value of the options.

Industry Context

Option repricing is a common practice to re-incentivize employees or executives when the stock price has fallen below the original option exercise price. It is often viewed as a way to retain talent and align their interests with shareholders.

Comparison to Industry Standards

• Option repricing is a fairly common practice, especially in volatile sectors like biotechnology, where Precipio operates.
• Companies like Exact Sciences and Guardant Health have also used stock options as part of their compensation packages to attract and retain key personnel.
• The specific terms of the repricing, such as the reversion clause, should be compared to industry benchmarks to assess its competitiveness and fairness.

Stakeholder Impact

• Shareholders may view the repricing positively if it incentivizes the director to improve company performance.
• Employees may see the repricing as a positive sign that the company is committed to retaining key personnel.
• The repricing has no direct impact on customers, suppliers, or creditors.

Key Dates

Keywords

stock options, Precipio, repricing, Form 4, director, Cossman, beneficial ownership